↓ Skip to main content

A real‐world efficacy and safety analysis of combined carfilzomib, lenalidomide, and dexamethasone (KRd) in relapsed/refractory multiple myeloma

Overview of attention for article published in Hematological Oncology, November 2020
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)
  • High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news
1 news outlet
twitter
2 X users
peer_reviews
1 peer review site

Citations

dimensions_citation
23 Dimensions

Readers on

mendeley
25 Mendeley